ANIP
NASDAQ · Pharmaceuticals
Ani Pharmaceuticals Inc
$78.25
-4.38 (-5.30%)
Open$77.09
Previous Close$82.63
Day High$78.59
Day Low$74.33
52W High$99.50
52W Low$64.99
Volume—
Avg Volume306.1K
Market Cap1.72B
P/E Ratio18.63
EPS$4.29
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
-53.1% upside
Current
$78.25
$78.25
Target
$36.71
$36.71
$28.36
$36.71 avg
$54.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 901.36M | 640.13M | 587.23M |
| Net Income | 79.93M | 51.09M | 76.98M |
| Profit Margin | 8.9% | 8.4% | 13.1% |
| EBITDA | 206.64M | 139.41M | 125.34M |
| Free Cash Flow | — | — | 59.62M |
| Rev Growth | +40.8% | +40.8% | +23.0% |
| Debt/Equity | 1.14 | 1.14 | 0.51 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |